Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

PHASE2TerminatedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

April 15, 2023

Study Completion Date

July 12, 2023

Conditions
Acute Kidney Injury
Interventions
DRUG

RMC-035

Concentrate for Solution for Infusion

DRUG

Placebo

Concentrate for Solution for Infusion

Trial Locations (29)

14621

Rochester Regional Health - Rochester General Hospital, Rochester

22908

University of Virginia (UVA) Health - University Hospital, Charlottesville

27710

Duke University Hospital, Durham

48604

Indiana Ohio Heart, Fort Wayne

53215

Aurora Health Care - Aurora St. Luke's Medical Center, Milwaukee

53706

University of Wisconsin, Madison

68506

Bryan Heart, Lincoln

75226

Baylor Scott and White Research Institute - Dallas, Dallas

Unknown

Hamilton Health Sciences, Hamilton

CHUM, Montreal

MUHC - Royal Victoria Hospital, Montreal

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec

St. John Regional Hospital, Saint John

Saint Michael's Hospital, Toronto

University Hospital Hradec Kralove, Hradec Králové

University Hospital Motol - Charles University Prague, Prague

Herz- und Diabeteszentrum Nordrhein-Westfalen (NRW), Bad Oeynhausen

Universitätsklinikum Köln, Cologne

Herzzentrum Dresden GmbH, Dresden

Westdeutsches Herzzentrum Essen, Essen

Universitätsklinikum Giessen und Marburg - Standort Giessen, Giessen

Universitätsklinikum Halle (Saale), Halle

Deutsches Herzzentrum München, München

Hospital Sant Pau, Barcelona

Reina Sofia University Hospital, Córdoba

Hospital de La Princesa, Madrid

Hospital Universitario Central de Asturias, Oviedo

Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela

DE-481 49

Münster University Hospital, Münster

Sponsors
All Listed Sponsors
lead

Guard Therapeutics AB

INDUSTRY

NCT05126303 - Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery | Biotech Hunter | Biotech Hunter